The primary purpose of this pilot study was to measure circulating sclerostin and examine scWAT for changes in sclerostin content and Wnt signaling (β‐catenin accumulation) following 4 weeks of sprint interval training (SIT) in young men with obesity. The gene discussed is SOST; the disease is obesity disorder.